Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

August 27, 2015August 27, 2015

Involved-Field Radiotherapy as the Best Care Option for Specific Hodgkin’s Lymphoma Patients

News

Researchers at the University Hospital Cologne and the University Hospital Münster in Germany recently reported that involved-field radiotherapy is the best treatment option for patients with a type of low-risk ... Read more

August 25, 2015August 25, 2015

Rituximab Plus Velcade as An Effective Therapy for Non-Hodgkin’s Lymphoma Subtypes

News

A Phase 2 clinical trial led by Dr. Kristie Blum at Ohio State University Comprehensive Cancer Center revealed encouraging results for the therapeutic combination of rituximab and Velcade in patients ... Read more

August 13, 2015August 13, 2015

Researchers Identify Mutations Underlying the Development of Rare Lymphoma

News

A study recently published in the journal Nature Genetics, led by researchers at Stanford University, revealed a group of mutations responsible for the development of a rare blood cancer – ... Read more

July 23, 2015July 23, 2015

Researchers Discover Link Between Specific Subset of Lymphomas and Metabolism

News

A new study led by researchers at the University of Texas Health Science Center at San Antonio has revealed a link between a type of lymphoma and a metabolism disruption. The ... Read more

June 9, 2015June 9, 2015

Cord Blood Registry Launches New Resource to Advance Stem Cell Research

News

Cord Blood Registry (CBR), the world’s largest newborn stem cell company, recently announced the launch of a Family Health Registry, a unique registry that offers insight into common conditions and ... Read more

June 8, 2015June 9, 2015

Social Network Analysis Useful To Identify Disease Biomarkers, Including Lymphoma

News

Researchers at TOBB University, Turkey, recently revealed that social network analysis (SNA) can be successfully employed in the identification of disease biomarkers, namely cancer biomarkers such as lymphoma. The study is ... Read more

June 4, 2015

Portola Pharmaceuticals Announces Encouraging Results For Cerdulatinib in Hematologic Cancer Patients

News

Portola Pharmaceuticals, Inc., a biopharmaceutical company focused on thrombosis and other hematologic diseases, recently announced positive safety and efficacy data on its product cerdulatinib in patients with hematologic cancers who ... Read more

June 2, 2015September 4, 2015

Mortality Rate Among Childhood Cancer Survivors On the Decline

News

Data on a study assessing the mortality rates among childhood cancer survivors was recently presented during the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, May 29 ... Read more

June 2, 2015August 23, 2016

Genentech’s Therapeutic Strategy for Indolent Non-Hodgkin’s Lymphoma Improves Patients’ Survival

News

Genentech, a member of the Roche Group focused on the treatment of serious or life-threatening medical conditions, recently announced new data on their Phase III GADOLIN trial (NCT01059630) on the ... Read more

May 29, 2015

NYU Langone Researchers Will Present New Data on Lymphoma Therapies in upcoming ASCO 2015 Meeting

News

Researchers at NYU Langone Medical Center and its associated Laura and Isaac Perlmutter Cancer Center, will be presenting close to 30 abstracts on topics such as lymphoma, pediatric cancer and ... Read more